Fundraising Fox
🦊/Companies
Sign in

Agitated Solutions

Saint Paul, US · Founded 2020 · Delaware corporation · 3 known investors

Find your way into Agitated Solutions

Agitated Solutions, Inc. (ASI) develops a saline microbubble contrast agent and delivery approach for cardiac bubble studies used to detect right-to-left shunts such as PFOs, aiming to remove manual saline agitation and let a single sonographer perform the study. Its products serve cardiac sonographers and echocardiography clinics, with a lead agent (ASI-02) in a US clinical trial and commercial availability in Canada and the EU.

BiotechHealthtechMedical Devices

Founders & leadership

ME
Morgan E. EvansNamed on SEC filing
MC
Morgan ClyburnNamed on SEC filing
RA
Robert A. KukuljanNamed on SEC filing

Board

KT
Kathleen TuneBoard director
ME
Micah EimerBoard director
MP
Mark PacynaBoard director
GM
Gerald MattysBoard director

Investors · 3

GROOVE CAPITALMinneapolis
Engage Venture Partnersreported

Also in the syndicate · 1

W. L. Gore & Associates

Reported raises · per SEC filings

Form D private placements

$9.9M disclosed across 5 rounds · 2021–2025

▶$6.5MraisedOct 2025 · 44 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathleen TuneDirector
  • Micah EimerDirector
  • Mark PacynaDirector
  • Gerald MattysDirector
  • Morgan E. EvansExecutive Officer, Director
Offering amount
$13.7M
Amount sold
$6.5M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$515KraisedMay 2022 · 11 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • ROBERT A. KUKULJANExecutive Officer
  • MORGAN EVANSExecutive Officer, Director
  • KATHLEEN TUNEDirector
  • MARK PACYNADirector
Offering amount
$750K
Amount sold
$515K
Minimum investment
$25K
First sale
Apr 2022
Incorporated
Limited Liability Company, Delaware, 2022
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.2MraisedApr 2022 · 15 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • MARK PACYNADirector
  • ROBERT A. KUKULJANExecutive Officer
  • MORGAN EVANSExecutive Officer, Director
  • MICAH EIMERDirector
  • KATHLEEN TUNEDirector
Offering amount
$3.5M
Amount sold
$1.2M
Minimum investment
$25K
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.6MraisedMar 2022 · 24 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Kathleen TuneDirector
  • Morgan EvansExecutive Officer, Director
  • Robert A. KukuljanExecutive Officer
  • Micah EimerDirector
  • Mark PacynaDirector
Offering amount
$1.6M
Amount sold
$1.6M
Minimum investment
$25K
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$80KraisedMar 2021 · 2 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Mark PacynaDirector
  • Morgan ClyburnExecutive Officer, Director
  • Robert A. KukuljanExecutive Officer
  • Kathleen TuneDirector
  • Micah EimerDirector
Offering amount
$1.3M
Amount sold
$80K
Minimum investment
$10K
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$305.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$282K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Agitated Solutions Announces W. L. Gore & Associates Joins Series B Investment Syndicateeinpresswire.com · Dec 2025Agitated Solutions, Inc. Receives Fast Track Designation for Investigational Drug ASI-02natlawreview.com · Oct 2025Morgan Evans | CEO, Agitated Solutions & Founder, Avio Medtech Consulting | Supporting & Accelerating MedTech Startups & Entrepreneurs | The Leading Differencetheleadingdifference.podbean.com · Sep 2025Agitated Solutions Receives IND Clearance from FDA to Initiate Phase 3 Clinical Trial of a Novel Contrast Agentbusinesswire.com · Apr 2025

Frequently asked questions

What does Agitated Solutions do?
Agitated Solutions, Inc. (ASI) develops a saline microbubble contrast agent and delivery approach for cardiac bubble studies used to detect right-to-left shunts such as PFOs, aiming to remove manual saline agitation and let a single sonographer perform the study. Its products serve cardiac sonographers and echocardiography clinics, with a lead agent (ASI-02) in a US clinical trial and commercial availability in Canada and the EU.
Who are Agitated Solutions's investors?
Agitated Solutions's investors include GROOVE CAPITAL, Engage Venture Partners.
How much funding has Agitated Solutions raised?
Agitated Solutions has disclosed $9.9M raised across 5 rounds.
Where is Agitated Solutions headquartered?
Agitated Solutions is headquartered in Saint Paul, US.